“A robust, above-ground retail marijuana market is necessary in order to disrupt the unregulated marketplace and to assure that consumers have adequate access to lab-tested, high quality products at competitive prices,” NORML’s Deputy Director Paul Armentano said.
“We are proud to launch adult use sales in Rhode Island just six months after the Cannabis Act was signed into law, marking the Northeast’s fastest implementation period,” said Matt Santacroce, interim deputy director of the Rhode Island Department of Business Regulation.
“A robust, above-ground retail marijuana market is necessary in order to disrupt the unregulated marketplace and to assure that consumers have adequate access to lab-tested, high quality products at competitive prices.”
“A robust, above-ground retail marijuana market is necessary in order to disrupt the unregulated marketplace and to assure that consumers have adequate access to lab-tested, high quality products at competitive prices.”
“Virginians 21 and older ought to have access at the already-operational dispensaries sooner rather than later, and they have been very clear in their demands to move earlier the date of sales,” said Jenn Michelle Pedini, NORML’s Development Director and the Executive Director of Virginia NORML.
“Virginians were expecting an opportunity to expedite retail sales and cannabusiness licensing in the 2022 General Assembly. Now, it appears that chance may have gone up in smoke, and instead a potential delay looms on the horizon.”
Long awaited sales of cannabis flower in Virginia began this month when medical dispensaries received the final product approvals from the state’s regulatory agency.
“These changes will help to establish a fair and diverse marketplace that reflects Vermont’s values and priorities.”